Be a Smart Investor
Thursday, January 19, 2017
Jazz Pharmaceuticals (JAZZ) Broke Out To Nearly A 4-Month High
Jazz Pharmaceuticals (JAZZ) announced after the bell Tuesday that the first patient has been enrolled in its Phase 3 clinical trial of defibrotide.
from RTT - Before the Bell http://ift.tt/2iNh1el
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment